• Thurs news: Novo Nordisk’s port strike distribution plan. Arcus/AZ renal cancer trial. Lilly weight loss drugs no longer in shortage. Difficulties of a CVS breakup. Google and Biontech AI lab assistants. See more on our front page

So what happened to Tildra. It was suppose to be HUGE


<







oh yea Sun has it and they blew it

Those thinking Tildra would be huge, probably should not have been hired in the first place. Delusional at best! That being said, Tildra can generate significant dollars that would make the rajas happy and lead to a satisfied sales force. Its all in the access. Until this SUN clown team fixes the HUB and managed care access, do not expect miracles. Giving Tildra away and internal finger pointing also yields setback. Grow up and focus on the prize.
 




Those thinking Tildra would be huge, probably should not have been hired in the first place. Delusional at best! That being said, Tildra can generate significant dollars that would make the rajas happy and lead to a satisfied sales force. Its all in the access. Until this SUN clown team fixes the HUB and managed care access, do not expect miracles. Giving Tildra away and internal finger pointing also yields setback. Grow up and focus on the prize.

Agreed!